EDVA · AMEX
Endovia Health Sciences (EDVA) Stock Price & Fundamentals
Endovia Health Sciences (EDVA) closed at $841.24 on Oct 9, 2026, down 1.33% from the previous close of $852.59.
Share price, past year
1Y +48.23%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $841.24 |
| Sep 30, 2026 | $859.57 |
| Aug 31, 2026 | $851.30 |
| Jul 31, 2026 | $834.16 |
| Jun 30, 2026 | $814.39 |
| May 29, 2026 | $736.50 |
| Apr 30, 2026 | $718.03 |
| Mar 31, 2026 | $727.54 |
| Feb 27, 2026 | $682.04 |
| Jan 30, 2026 | $688.60 |
| Dec 31, 2025 | $631.22 |
| Nov 28, 2025 | $588.45 |
| Oct 31, 2025 | $590.87 |
Key statistics
- Market cap
- $630.47M
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$17.28M
- Shares outstanding
- 749.5K
- Dividend yield
- —
- 52-week range
- $567.51 – $885.82
Endovia Health Sciences's market cap is $630.47M, based on a share price of $841.24 and 749.5K shares outstanding as of Jun 30, 2026.
Financials
Endovia Health Sciences reported revenue of $73.07K for fiscal 2025, down 90.88% from fiscal 2024.
Endovia Health Sciences reported a net loss of $25.23M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $73.07K | −90.9% | −$25.23M | −34,537.0% | −$11.97 | — |
| FY2024ended Dec 31, 2024 | $801.27K | −95.8% | −$23.76M | −2,964.9% | −$17.68 | — |
| FY2023ended Dec 31, 2023 | $18.85M | +4.2% | −$21.00M | −111.4% | — | — |
| FY2022ended Dec 31, 2022 | $18.09M | +59.8% | −$21.69M | −119.9% | — | — |
| FY2021ended Dec 31, 2021 | $11.32M | +392.0% | −$29.05M | −256.7% | −$1.02 | — |
| FY2020ended Dec 31, 2020 | $2.30M | +11,182.3% | −$28.67M | −1,246.7% | −$1.06 | — |
| FY2019ended Dec 31, 2019 | $20.39K | −98.4% | −$5.14M | −25,191.2% | −$0.04 | — |
| FY2018ended Dec 31, 2018 | $1.31M | +46.2% | $68.21K | 5.2% | $0.01 | — |
| FY2017ended Dec 31, 2017 | $895.35K | −11.6% | −$147.53K | −16.5% | −$0.01 | — |
| FY2016ended Dec 31, 2016 | $1.01M | — | −$48.85K | −4.8% | $0.00 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $4.22K | −$2.14M | −$0.47 |
| Q1 FY2025ended Mar 31, 2025 | $68.61K | −$3.65M | −$1.97 |
| Q3 FY2024ended Sep 30, 2024 | $981.86K | −$4.72M | — |
| Q2 FY2024ended Jun 30, 2024 | $1.05M | — | — |
| Q1 FY2024ended Mar 31, 2024 | $1.54M | — | — |
| Q4 FY2023ended Dec 31, 2023 | $2.69M | — | — |
| Q3 FY2023ended Sep 30, 2023 | $5.14M | — | −$0.13 |
| Q2 FY2023ended Jun 30, 2023 | $5.19M | — | −$0.13 |
Company profile
- Name
- Endovia Health Sciences, Inc.
- Ticker
- EDVA
- Exchange
- AMEX
- Industry (SEC SIC)
- Beverages
- Headquarters
- 1112 N Flagler Drive, Fort Lauderdale, FL 33304
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001553788
Recent SEC filings
- Oct 6, 2026
- Oct 5, 2026
- Sep 24, 2026
- Sep 22, 2026
- Aug 31, 2026
- Aug 28, 2026
- Aug 26, 2026
- Aug 25, 2026
Frequently asked questions
What is Endovia Health Sciences's stock price?
Endovia Health Sciences (EDVA) closed at $841.24 on Oct 9, 2026, down 1.33% from the previous close of $852.59.
What is Endovia Health Sciences's market cap?
Endovia Health Sciences's market cap is $630.47M, based on a share price of $841.24 and 749.5K shares outstanding as of Jun 30, 2026.
How much revenue does Endovia Health Sciences make?
Endovia Health Sciences reported revenue of $73.07K for fiscal 2025, down 90.88% from fiscal 2024.
Does Endovia Health Sciences pay a dividend?
Endovia Health Sciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Endovia Health Sciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures